ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Lipid transfers to HDL are diminished in women with overt hypothyroidism after total thyroidectomy (2018)
Sigal, Gilbert Alexandre; Tavoni, Thauany Martins; Freitas, Fatima Rodrigues de; Silva, Bruna Miranda de Oliveira; Brandão, Lenine Garcia; Maranhão, Raul Cavalcante
Source: Atherosclerosis. Conference titles: Congress of the European Atherosclerosis Society/EAS. Unidades: FM, FCF
Subjects: LIPÍDEOS, HIPOTIREOIDISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SIGAL, Gilbert Alexandre et al. Lipid transfers to HDL are diminished in women with overt hypothyroidism after total thyroidectomy. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf. Acesso em: 07 nov. 2024. , 2018
APA
Sigal, G. A., Tavoni, T. M., Freitas, F. R. de, Silva, B. M. de O., Brandão, L. G., & Maranhão, R. C. (2018). Lipid transfers to HDL are diminished in women with overt hypothyroidism after total thyroidectomy. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
NLM
Sigal GA, Tavoni TM, Freitas FR de, Silva BM de O, Brandão LG, Maranhão RC. Lipid transfers to HDL are diminished in women with overt hypothyroidism after total thyroidectomy [Internet]. Atherosclerosis. 2018 ; 275 e167 res. P2.5.217.[citado 2024 nov. 07 ] Available from: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
Vancouver
Sigal GA, Tavoni TM, Freitas FR de, Silva BM de O, Brandão LG, Maranhão RC. Lipid transfers to HDL are diminished in women with overt hypothyroidism after total thyroidectomy [Internet]. Atherosclerosis. 2018 ; 275 e167 res. P2.5.217.[citado 2024 nov. 07 ] Available from: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
Trabalho de evento-resumo periodico
Chylomicron metabolism is impaired in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure (2018)
Drager, Luciano Ferreira; Tavoni, Thauany Martins; Silva, Vanessa Martins da; Santos, Raul Dias dos; Pedrosa, Rodrigo Pinto; Bortolotto, Luiz Aparecido; Vinagre, Carmen Guilherme Christiano de Matos; Polotsky, Vsevolod Y; Lorenzi Filho, Geraldo; Maranhão, Raul Cavalcante
Source: Atherosclerosis. Conference titles: Congress of the European Atherosclerosis Society/EAS. Unidades: FM, FCF
Subjects: APNEIA DO SONO, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DRAGER, Luciano Ferreira et al. Chylomicron metabolism is impaired in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf. Acesso em: 07 nov. 2024. , 2018
APA
Drager, L. F., Tavoni, T. M., Silva, V. M. da, Santos, R. D. dos, Pedrosa, R. P., Bortolotto, L. A., et al. (2018). Chylomicron metabolism is impaired in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
NLM
Drager LF, Tavoni TM, Silva VM da, Santos RD dos, Pedrosa RP, Bortolotto LA, Vinagre CGC de M, Polotsky VY, Lorenzi Filho G, Maranhão RC. Chylomicron metabolism is impaired in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure [Internet]. Atherosclerosis. 2018 ; 275 e157 res. P2.2.182.[citado 2024 nov. 07 ] Available from: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
Vancouver
Drager LF, Tavoni TM, Silva VM da, Santos RD dos, Pedrosa RP, Bortolotto LA, Vinagre CGC de M, Polotsky VY, Lorenzi Filho G, Maranhão RC. Chylomicron metabolism is impaired in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure [Internet]. Atherosclerosis. 2018 ; 275 e157 res. P2.2.182.[citado 2024 nov. 07 ] Available from: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
Trabalho de evento-resumo periodico
Plasma clearance of chylomicron remnants is delayed in aged subjects: a study with artificial emulsions (2018)
Tavoni, Thauany Martins; Vinagre, Carmen Guilherme Christiano de Matos; Freitas, Fatima Rodrigues; Mesquita, Carlos Henrique de; Vinagre, Juliana Christiano de Matos; Mariani, A. C; Kalil Filho, Roberto; Maranhão, Raul Cavalcante
Source: Atherosclerosis. Conference titles: Congress of the European Atherosclerosis Society/EAS. Unidades: FM, FCF
Subjects: EMULSÕES (FORMAS FARMACÊUTICAS), DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAVONI, Thauany Martins et al. Plasma clearance of chylomicron remnants is delayed in aged subjects: a study with artificial emulsions. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf. Acesso em: 07 nov. 2024. , 2018
APA
Tavoni, T. M., Vinagre, C. G. C. de M., Freitas, F. R., Mesquita, C. H. de, Vinagre, J. C. de M., Mariani, A. C., et al. (2018). Plasma clearance of chylomicron remnants is delayed in aged subjects: a study with artificial emulsions. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
NLM
Tavoni TM, Vinagre CGC de M, Freitas FR, Mesquita CH de, Vinagre JC de M, Mariani AC, Kalil Filho R, Maranhão RC. Plasma clearance of chylomicron remnants is delayed in aged subjects: a study with artificial emulsions [Internet]. Atherosclerosis. 2018 ; 275 e157 res. P2.2.181.[citado 2024 nov. 07 ] Available from: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
Vancouver
Tavoni TM, Vinagre CGC de M, Freitas FR, Mesquita CH de, Vinagre JC de M, Mariani AC, Kalil Filho R, Maranhão RC. Plasma clearance of chylomicron remnants is delayed in aged subjects: a study with artificial emulsions [Internet]. Atherosclerosis. 2018 ; 275 e157 res. P2.2.181.[citado 2024 nov. 07 ] Available from: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
Trabalho de evento-resumo periodico
Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model (2018)
Meneghini, Bianca Correa; Tavares, Elaine Rufo; Guido, Maria Carolina; Tavoni, Thauany Martins; Kalil Filho, Roberto; Maranhão, Raul Cavalcante
Source: Atherosclerosis. Conference titles: International Symposium on Atherosclerosis/ISA. Unidades: FM, FCF
Subjects: NANOPARTÍCULAS, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MENEGHINI, Bianca Correa et al. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf. Acesso em: 07 nov. 2024. , 2018
APA
Meneghini, B. C., Tavares, E. R., Guido, M. C., Tavoni, T. M., Kalil Filho, R., & Maranhão, R. C. (2018). Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
NLM
Meneghini BC, Tavares ER, Guido MC, Tavoni TM, Kalil Filho R, Maranhão RC. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model [Internet]. Atherosclerosis. 2018 ; 32 112-113 res. P3.088.[citado 2024 nov. 07 ] Available from: https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
Vancouver
Meneghini BC, Tavares ER, Guido MC, Tavoni TM, Kalil Filho R, Maranhão RC. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model [Internet]. Atherosclerosis. 2018 ; 32 112-113 res. P3.088.[citado 2024 nov. 07 ] Available from: https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
Trabalho de evento-resumo periodico
Plasma kinetics of chylomicron in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure (2018)
Drager, Luciano Ferreira; Tavoni, Thauany Martins; Silva, Vanessa Martins da; Santos, Raul Dias dos; Pedrosa, Rodrigo Pinto; Bortolotto, Luiz Aparecido; Vinagre, Carmen Guilherme Christiano de Matos; Polotsky, Vsevolod Y; Lorenzi Filho, Geraldo; Maranhão, Raul Cavalcante
Source: Atherosclerosis. Conference titles: International Symposium on Atherosclerosis/ISA. Unidades: FM, FCF
Subjects: APNEIA DO SONO, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DRAGER, Luciano Ferreira et al. Plasma kinetics of chylomicron in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf. Acesso em: 07 nov. 2024. , 2018
APA
Drager, L. F., Tavoni, T. M., Silva, V. M. da, Santos, R. D. dos, Pedrosa, R. P., Bortolotto, L. A., et al. (2018). Plasma kinetics of chylomicron in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
NLM
Drager LF, Tavoni TM, Silva VM da, Santos RD dos, Pedrosa RP, Bortolotto LA, Vinagre CGC de M, Polotsky VY, Lorenzi Filho G, Maranhão RC. Plasma kinetics of chylomicron in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure [Internet]. Atherosclerosis. 2018 ; 32 63-64 res. P1.099.[citado 2024 nov. 07 ] Available from: https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
Vancouver
Drager LF, Tavoni TM, Silva VM da, Santos RD dos, Pedrosa RP, Bortolotto LA, Vinagre CGC de M, Polotsky VY, Lorenzi Filho G, Maranhão RC. Plasma kinetics of chylomicron in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure [Internet]. Atherosclerosis. 2018 ; 32 63-64 res. P1.099.[citado 2024 nov. 07 ] Available from: https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
Trabalho de evento-resumo periodico
Lipid core nanoparticle associated with docetaxel reduces inflammation and cell proliferation in an atherosclerosis rabbit model (2018)
Guido, Maria Carolina; Meneghini, Bianca Correa; Tavares, Elaine Rufo; Tavoni, Thauany Martins; Kalil Filho, Roberto; Maranhão, Raul Cavalcante
Source: Atherosclerosis. Conference titles: Congress of the European Atherosclerosis Society/EAS. Unidades: FM, FCF
Subjects: ARTERIOSCLEROSE, NANOPARTÍCULAS, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIDO, Maria Carolina et al. Lipid core nanoparticle associated with docetaxel reduces inflammation and cell proliferation in an atherosclerosis rabbit model. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf. Acesso em: 07 nov. 2024. , 2018
APA
Guido, M. C., Meneghini, B. C., Tavares, E. R., Tavoni, T. M., Kalil Filho, R., & Maranhão, R. C. (2018). Lipid core nanoparticle associated with docetaxel reduces inflammation and cell proliferation in an atherosclerosis rabbit model. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
NLM
Guido MC, Meneghini BC, Tavares ER, Tavoni TM, Kalil Filho R, Maranhão RC. Lipid core nanoparticle associated with docetaxel reduces inflammation and cell proliferation in an atherosclerosis rabbit model [Internet]. Atherosclerosis. 2018 ; 275 e49 res. SAG19.5.[citado 2024 nov. 07 ] Available from: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
Vancouver
Guido MC, Meneghini BC, Tavares ER, Tavoni TM, Kalil Filho R, Maranhão RC. Lipid core nanoparticle associated with docetaxel reduces inflammation and cell proliferation in an atherosclerosis rabbit model [Internet]. Atherosclerosis. 2018 ; 275 e49 res. SAG19.5.[citado 2024 nov. 07 ] Available from: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
Trabalho de evento-resumo periodico
Effects of treatment with methotrexate associated to lipid nanoparticles on diabetic cardiomyopathy in rats (2017)
Maranhão, Raul Cavalcante ; Marques, Alyne França; Guido, Maria Carolina; Tavares, Elaine Rufo; Bispo, Deborah Lima; Melo, Marcelo Dantas Tavares de; Salemi, Vera Maria Cury
Source: Atherosclerosis. Conference titles: European Atherosclerosis Society Congress (EAS). Unidade: FCF
Subjects: NANOPARTÍCULAS, RATOS, METOTREXATO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARANHÃO, Raul Cavalcante et al. Effects of treatment with methotrexate associated to lipid nanoparticles on diabetic cardiomyopathy in rats. Atherosclerosis. Clare: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 07 nov. 2024. , 2017
APA
Maranhão, R. C., Marques, A. F., Guido, M. C., Tavares, E. R., Bispo, D. L., Melo, M. D. T. de, & Salemi, V. M. C. (2017). Effects of treatment with methotrexate associated to lipid nanoparticles on diabetic cardiomyopathy in rats. Atherosclerosis. Clare: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Maranhão RC, Marques AF, Guido MC, Tavares ER, Bispo DL, Melo MDT de, Salemi VMC. Effects of treatment with methotrexate associated to lipid nanoparticles on diabetic cardiomyopathy in rats. Atherosclerosis. 2017 ; 263 e48 res. SAG052.[citado 2024 nov. 07 ]
Vancouver
Maranhão RC, Marques AF, Guido MC, Tavares ER, Bispo DL, Melo MDT de, Salemi VMC. Effects of treatment with methotrexate associated to lipid nanoparticles on diabetic cardiomyopathy in rats. Atherosclerosis. 2017 ; 263 e48 res. SAG052.[citado 2024 nov. 07 ]
Trabalho de evento-resumo periodico
Plasma lipids and lipid transfer to HDL in long-term bedridden and in sedentary subjects (2017)
Maranhão, Raul Cavalcante ; Oliveira, Wilson Camargo; Tavoni, Thauany Martins; Freitas, Fatima Rodrigues; Silva, Bruna Miranda; Kalil Filho, Roberto
Source: Atherosclerosis. Conference titles: European Atherosclerosis Society Congress (EAS). Unidades: FCF, FM
Subjects: SEDENTARISMO, LIPÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARANHÃO, Raul Cavalcante et al. Plasma lipids and lipid transfer to HDL in long-term bedridden and in sedentary subjects. Atherosclerosis. Amsterdam: Elsevier. Disponível em: https://doi.org/10.1016/j.atherosclerosis.2017.06.704. Acesso em: 07 nov. 2024. , 2017
APA
Maranhão, R. C., Oliveira, W. C., Tavoni, T. M., Freitas, F. R., Silva, B. M., & Kalil Filho, R. (2017). Plasma lipids and lipid transfer to HDL in long-term bedridden and in sedentary subjects. Atherosclerosis. Amsterdam: Elsevier. doi:10.1016/j.atherosclerosis.2017.06.704
NLM
Maranhão RC, Oliveira WC, Tavoni TM, Freitas FR, Silva BM, Kalil Filho R. Plasma lipids and lipid transfer to HDL in long-term bedridden and in sedentary subjects [Internet]. Atherosclerosis. 2017 ; 263 e216.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2017.06.704
Vancouver
Maranhão RC, Oliveira WC, Tavoni TM, Freitas FR, Silva BM, Kalil Filho R. Plasma lipids and lipid transfer to HDL in long-term bedridden and in sedentary subjects [Internet]. Atherosclerosis. 2017 ; 263 e216.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2017.06.704
Trabalho de evento-resumo periodico
Lipids transfer to HDL in patients with heart failure was diminished and is correlated with IL-6 and BNP levels (2017)
Martine, Ana Elisa Marabini; Carvalho, Priscila O; Curiati, Milena N. C; Miranda, Bruna O; Freitas, Fatima R; Kalil Filho, Roberto; Barretto, Antonio Carlos Pereira; Maranhão, Raul Cavalcante
Source: Atherosclerosis. Conference titles: European Atherosclerosis Society Congress (EAS). Unidades: FCF, FM
Subjects: INSUFICIÊNCIA CARDÍACA, LIPOPROTEÍNAS HDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINE, Ana Elisa Marabini et al. Lipids transfer to HDL in patients with heart failure was diminished and is correlated with IL-6 and BNP levels. Atherosclerosis. Amsterdam: Elsevier. Disponível em: https://doi.org/10.1016/j.atherosclerosis.2017.06.243. Acesso em: 07 nov. 2024. , 2017
APA
Martine, A. E. M., Carvalho, P. O., Curiati, M. N. C., Miranda, B. O., Freitas, F. R., Kalil Filho, R., et al. (2017). Lipids transfer to HDL in patients with heart failure was diminished and is correlated with IL-6 and BNP levels. Atherosclerosis. Amsterdam: Elsevier. doi:10.1016/j.atherosclerosis.2017.06.243
NLM
Martine AEM, Carvalho PO, Curiati MNC, Miranda BO, Freitas FR, Kalil Filho R, Barretto ACP, Maranhão RC. Lipids transfer to HDL in patients with heart failure was diminished and is correlated with IL-6 and BNP levels [Internet]. Atherosclerosis. 2017 ; 263 e073.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2017.06.243
Vancouver
Martine AEM, Carvalho PO, Curiati MNC, Miranda BO, Freitas FR, Kalil Filho R, Barretto ACP, Maranhão RC. Lipids transfer to HDL in patients with heart failure was diminished and is correlated with IL-6 and BNP levels [Internet]. Atherosclerosis. 2017 ; 263 e073.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2017.06.243
Trabalho de evento-resumo periodico
Differences in lipid transfers to HDL between patients with coronary arterial disease with or without type 2 diabetes mellitus (2017)
Maranhão, Raul Cavalcante ; Tavoni, Thauany Martins; Laverdy Neto, Oscar Giese; Sprandel, Marília da Costa Oliveira; Kalil Filho, Roberto; Hueb, Whady Armindo
Source: Atherosclerosis. Conference titles: European Atherosclerosis Society Congress (EAS). Unidades: FCF, FM
Subjects: DIABETES MELLITUS, DOENÇAS CARDIOVASCULARES, LIPÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARANHÃO, Raul Cavalcante et al. Differences in lipid transfers to HDL between patients with coronary arterial disease with or without type 2 diabetes mellitus. Atherosclerosis. Amsterdam: Elsevier. Disponível em: https://doi.org/10.1016/j.atherosclerosis.2017.06.706. Acesso em: 07 nov. 2024. , 2017
APA
Maranhão, R. C., Tavoni, T. M., Laverdy Neto, O. G., Sprandel, M. da C. O., Kalil Filho, R., & Hueb, W. A. (2017). Differences in lipid transfers to HDL between patients with coronary arterial disease with or without type 2 diabetes mellitus. Atherosclerosis. Amsterdam: Elsevier. doi:10.1016/j.atherosclerosis.2017.06.706
NLM
Maranhão RC, Tavoni TM, Laverdy Neto OG, Sprandel M da CO, Kalil Filho R, Hueb WA. Differences in lipid transfers to HDL between patients with coronary arterial disease with or without type 2 diabetes mellitus [Internet]. Atherosclerosis. 2017 ; 263 e217.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2017.06.706
Vancouver
Maranhão RC, Tavoni TM, Laverdy Neto OG, Sprandel M da CO, Kalil Filho R, Hueb WA. Differences in lipid transfers to HDL between patients with coronary arterial disease with or without type 2 diabetes mellitus [Internet]. Atherosclerosis. 2017 ; 263 e217.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2017.06.706
Trabalho de evento-resumo periodico
Methotrexate carried in lipid core nanoparticles reduced the infarction size and improved left ventricle function following acute myocardium infarction induced in rats (2017)
Maranhão, Raul Cavalcante ; Guido, Maria Carolina; Marques, Alyne França; Tavares, Elaine Rufo; Bispo, Deborah Lima; Melo, Marcelo Dantas Tavares de; Lima, Aline Derísio; Nicolau, José Carlos; Salemi, Vera Maria; Kalil Filho, Roberto
Source: Atherosclerosis. Conference titles: European Atherosclerosis Society Congress (EAS). Unidades: FCF, FM
Subjects: INFARTO DO MIOCÁRDIO, NANOPARTÍCULAS, RATOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARANHÃO, Raul Cavalcante et al. Methotrexate carried in lipid core nanoparticles reduced the infarction size and improved left ventricle function following acute myocardium infarction induced in rats. Atherosclerosis. Amsterdam: Elsevier. Disponível em: https://doi.org/10.1016/j.atherosclerosis.2017.06.405. Acesso em: 07 nov. 2024. , 2017
APA
Maranhão, R. C., Guido, M. C., Marques, A. F., Tavares, E. R., Bispo, D. L., Melo, M. D. T. de, et al. (2017). Methotrexate carried in lipid core nanoparticles reduced the infarction size and improved left ventricle function following acute myocardium infarction induced in rats. Atherosclerosis. Amsterdam: Elsevier. doi:10.1016/j.atherosclerosis.2017.06.405
NLM
Maranhão RC, Guido MC, Marques AF, Tavares ER, Bispo DL, Melo MDT de, Lima AD, Nicolau JC, Salemi VM, Kalil Filho R. Methotrexate carried in lipid core nanoparticles reduced the infarction size and improved left ventricle function following acute myocardium infarction induced in rats [Internet]. Atherosclerosis. 2017 ; 263 e126.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2017.06.405
Vancouver
Maranhão RC, Guido MC, Marques AF, Tavares ER, Bispo DL, Melo MDT de, Lima AD, Nicolau JC, Salemi VM, Kalil Filho R. Methotrexate carried in lipid core nanoparticles reduced the infarction size and improved left ventricle function following acute myocardium infarction induced in rats [Internet]. Atherosclerosis. 2017 ; 263 e126.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2017.06.405
Artigo de periodico
Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects (2014)
Mangili, Otavio Celeste; Gagliardi, Ana C. Moron; Mangili, Leonardo Celeste; Mesquita, Carlos H.; Cesar, Luiz A. Machado; Tanaka, Akira; Schaefer, Ernst J.; Maranhão, Raul Cavalcante ; Santos, Raul D.
Source: Atherosclerosis. Unidades: FM, FCF
Subjects: LIPOPROTEÍNAS (TERAPIA), DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MANGILI, Otavio Celeste et al. Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects. Atherosclerosis, v. 233, n. 1, p. 319-325, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2013.12.008. Acesso em: 07 nov. 2024.
APA
Mangili, O. C., Gagliardi, A. C. M., Mangili, L. C., Mesquita, C. H., Cesar, L. A. M., Tanaka, A., et al. (2014). Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects. Atherosclerosis, 233( 1), 319-325. doi:10.1016/j.atherosclerosis.2013.12.008
NLM
Mangili OC, Gagliardi ACM, Mangili LC, Mesquita CH, Cesar LAM, Tanaka A, Schaefer EJ, Maranhão RC, Santos RD. Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects [Internet]. Atherosclerosis. 2014 ; 233( 1): 319-325.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2013.12.008
Vancouver
Mangili OC, Gagliardi ACM, Mangili LC, Mesquita CH, Cesar LAM, Tanaka A, Schaefer EJ, Maranhão RC, Santos RD. Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects [Internet]. Atherosclerosis. 2014 ; 233( 1): 319-325.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2013.12.008
Artigo de periodico
Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects (2014)
Mangili, Otavio Celeste; Gagliardi, Ana Carolina Moron; Mangili, Leonardo Celeste; Mesquita, Carlos Henrique de; Cesar, Luiz Antonio Machado; Tanaka, Akira; Schaefer, Ernst J; Maranhão, Raul Cavalcante ; Santos, Raul Dias
Source: Atherosclerosis. Unidades: FM, FCF
Subjects: EMULSÕES (FORMAS FARMACÊUTICAS), DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MANGILI, Otavio Celeste et al. Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects. Atherosclerosis, v. 233, n. 1, p. 319-325, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2013.12.008. Acesso em: 07 nov. 2024.
APA
Mangili, O. C., Gagliardi, A. C. M., Mangili, L. C., Mesquita, C. H. de, Cesar, L. A. M., Tanaka, A., et al. (2014). Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects. Atherosclerosis, 233( 1), 319-325. doi:10.1016/j.atherosclerosis.2013.12.008
NLM
Mangili OC, Gagliardi ACM, Mangili LC, Mesquita CH de, Cesar LAM, Tanaka A, Schaefer EJ, Maranhão RC, Santos RD. Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects [Internet]. Atherosclerosis. 2014 ; 233( 1): 319-325.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2013.12.008
Vancouver
Mangili OC, Gagliardi ACM, Mangili LC, Mesquita CH de, Cesar LAM, Tanaka A, Schaefer EJ, Maranhão RC, Santos RD. Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects [Internet]. Atherosclerosis. 2014 ; 233( 1): 319-325.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2013.12.008
Trabalho de evento-resumo periodico
In both genders, high rate unesterified cholesterol transfer to HDL in the plasma can be protective against coronary artery disease (2014)
Sprandel, Marilia da Costa Oliveira; Hueb, Whady Armindo; Segre, Alexandre; Laverdy Neto, Oscar Giese; Leite Junior, Antonio Carlos de Arruda; Freitas, Fátima Rodrigues; Kalil Filho, Roberto; Maranhão, Raul Cavalcante
Source: Atherosclerosis. Conference titles: European Atherosclerosis Society Congress (EAS). Unidades: FM, FCF
Subjects: LIPOPROTEÍNAS LDL, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SPRANDEL, Marilia da Costa Oliveira et al. In both genders, high rate unesterified cholesterol transfer to HDL in the plasma can be protective against coronary artery disease. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 07 nov. 2024. , 2014
APA
Sprandel, M. da C. O., Hueb, W. A., Segre, A., Laverdy Neto, O. G., Leite Junior, A. C. de A., Freitas, F. R., et al. (2014). In both genders, high rate unesterified cholesterol transfer to HDL in the plasma can be protective against coronary artery disease. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo.
NLM
Sprandel M da CO, Hueb WA, Segre A, Laverdy Neto OG, Leite Junior AC de A, Freitas FR, Kalil Filho R, Maranhão RC. In both genders, high rate unesterified cholesterol transfer to HDL in the plasma can be protective against coronary artery disease. Atherosclerosis. 2014 ; 235( 2): e102-e103 res. EAS-0801.[citado 2024 nov. 07 ]
Vancouver
Sprandel M da CO, Hueb WA, Segre A, Laverdy Neto OG, Leite Junior AC de A, Freitas FR, Kalil Filho R, Maranhão RC. In both genders, high rate unesterified cholesterol transfer to HDL in the plasma can be protective against coronary artery disease. Atherosclerosis. 2014 ; 235( 2): e102-e103 res. EAS-0801.[citado 2024 nov. 07 ]
Trabalho de evento-resumo periodico
In both genders, high rate unesterified cholesterol transfer to hdl in the plasma can be protective against coronary artery disease (2014)
Sprandel, M. C. O.; Hueb, W. A.; Segre, A. C.; Laverdy, O. G.; Leite-Júnior, A. C.; Freitas, F. R.; Kalil-Filho, R.; Maranhão, Raul Cavalcante
Source: Atherosclerosis. Conference titles: European Atherosclerosis Society Congress (EAS). Unidades: FM, FCF
Subjects: COLESTEROL (METABOLISMO;SÍNTESE), PLASMA, DOENÇAS CARDIOVASCULARES, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SPRANDEL, M. C. O. et al. In both genders, high rate unesterified cholesterol transfer to hdl in the plasma can be protective against coronary artery disease. Atherosclerosis. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.sciencedirect.com/science/article/pii/S0021915014005115. Acesso em: 07 nov. 2024. , 2014
APA
Sprandel, M. C. O., Hueb, W. A., Segre, A. C., Laverdy, O. G., Leite-Júnior, A. C., Freitas, F. R., et al. (2014). In both genders, high rate unesterified cholesterol transfer to hdl in the plasma can be protective against coronary artery disease. Atherosclerosis. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.sciencedirect.com/science/article/pii/S0021915014005115
NLM
Sprandel MCO, Hueb WA, Segre AC, Laverdy OG, Leite-Júnior AC, Freitas FR, Kalil-Filho R, Maranhão RC. In both genders, high rate unesterified cholesterol transfer to hdl in the plasma can be protective against coronary artery disease [Internet]. Atherosclerosis. 2014 ; 235( 2): e101-e102.[citado 2024 nov. 07 ] Available from: http://www.sciencedirect.com/science/article/pii/S0021915014005115
Vancouver
Sprandel MCO, Hueb WA, Segre AC, Laverdy OG, Leite-Júnior AC, Freitas FR, Kalil-Filho R, Maranhão RC. In both genders, high rate unesterified cholesterol transfer to hdl in the plasma can be protective against coronary artery disease [Internet]. Atherosclerosis. 2014 ; 235( 2): e101-e102.[citado 2024 nov. 07 ] Available from: http://www.sciencedirect.com/science/article/pii/S0021915014005115
Artigo de periodico
The removal from plasma of chylomicrons and remnants is reduced in heterozygous familial hypercholesterolemia subjects with identified LDL receptor mutations: Study with artificial emulsions (2012)
Carneiro, Marcia M.; Miname, Marcio H.; Gagliardi, Ana C.; Pereira, Carolina; Pereira, Alexandre C.; Krieger, José Eduardo; Maranhão, Raul Cavalcante ; Santos, Raul D.
Source: Atherosclerosis. Unidades: FM, FCF
Subjects: PLASMA, HIPERCOLESTEROLEMIA (GENÉTICA;METABOLISMO), DOENÇAS HEREDITÁRIAS, LIPOPROTEÍNAS LDL, EMULSÕES (FORMAS FARMACÊUTICAS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARNEIRO, Marcia M. et al. The removal from plasma of chylomicrons and remnants is reduced in heterozygous familial hypercholesterolemia subjects with identified LDL receptor mutations: Study with artificial emulsions. Atherosclerosis, v. 221, n. 1, p. 268-274, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2011.12.033. Acesso em: 07 nov. 2024.
APA
Carneiro, M. M., Miname, M. H., Gagliardi, A. C., Pereira, C., Pereira, A. C., Krieger, J. E., et al. (2012). The removal from plasma of chylomicrons and remnants is reduced in heterozygous familial hypercholesterolemia subjects with identified LDL receptor mutations: Study with artificial emulsions. Atherosclerosis, 221( 1), 268-274. doi:10.1016/j.atherosclerosis.2011.12.033
NLM
Carneiro MM, Miname MH, Gagliardi AC, Pereira C, Pereira AC, Krieger JE, Maranhão RC, Santos RD. The removal from plasma of chylomicrons and remnants is reduced in heterozygous familial hypercholesterolemia subjects with identified LDL receptor mutations: Study with artificial emulsions [Internet]. Atherosclerosis. 2012 ; 221( 1): 268-274.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2011.12.033
Vancouver
Carneiro MM, Miname MH, Gagliardi AC, Pereira C, Pereira AC, Krieger JE, Maranhão RC, Santos RD. The removal from plasma of chylomicrons and remnants is reduced in heterozygous familial hypercholesterolemia subjects with identified LDL receptor mutations: Study with artificial emulsions [Internet]. Atherosclerosis. 2012 ; 221( 1): 268-274.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2011.12.033
Artigo de periodico
Resistance training changes LDL metabolism in normolipidemic subjects: A study with a nanoemulsion mimetic of LDL (2011)
Silva, Jeferson Luis da; Vinagre, Carmen Guilherme Christiano de Matos; Morikawa, Aleksandra Tiemi; Alves, Maria Janieire de Nazaré Nunes; Mesquita, Carlos Henrique de; Maranhão, Raul Cavalcante
Source: Atherosclerosis. Unidade: FCF
Subjects: NANOPARTÍCULAS, COLESTEROL, LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Jeferson Luis da et al. Resistance training changes LDL metabolism in normolipidemic subjects: A study with a nanoemulsion mimetic of LDL. Atherosclerosis, v. 219, n. 2, p. 532-537, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2011.08.014. Acesso em: 07 nov. 2024.
APA
Silva, J. L. da, Vinagre, C. G. C. de M., Morikawa, A. T., Alves, M. J. de N. N., Mesquita, C. H. de, & Maranhão, R. C. (2011). Resistance training changes LDL metabolism in normolipidemic subjects: A study with a nanoemulsion mimetic of LDL. Atherosclerosis, 219( 2), 532-537. doi:10.1016/j.atherosclerosis.2011.08.014
NLM
Silva JL da, Vinagre CGC de M, Morikawa AT, Alves MJ de NN, Mesquita CH de, Maranhão RC. Resistance training changes LDL metabolism in normolipidemic subjects: A study with a nanoemulsion mimetic of LDL [Internet]. Atherosclerosis. 2011 ; 219( 2): 532-537.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2011.08.014
Vancouver
Silva JL da, Vinagre CGC de M, Morikawa AT, Alves MJ de NN, Mesquita CH de, Maranhão RC. Resistance training changes LDL metabolism in normolipidemic subjects: A study with a nanoemulsion mimetic of LDL [Internet]. Atherosclerosis. 2011 ; 219( 2): 532-537.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2011.08.014
Artigo de periodico
Exercise training accelerates the removal from plasma of LDL-like nanoemulsion in moderately hypercholesterolemic subjects (2010)
Ficker, Elisabeth S; Maranhão, Raul Cavalcante ; Chacra, Ana P. M.; Neves, Vanessa C.; Negrão, C. E.; Martins, Vanessa C. N.; Vinagre, Carmen G. C. de M.
Source: Atherosclerosis. Unidades: EEFE, FCF
Subjects: FISIOLOGIA DO EXERCÍCIO, EXERCÍCIO FÍSICO, COLESTEROL, DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FICKER, Elisabeth S et al. Exercise training accelerates the removal from plasma of LDL-like nanoemulsion in moderately hypercholesterolemic subjects. Atherosclerosis, v. 212, n. 1, p. 230-236, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2010.04.030. Acesso em: 07 nov. 2024.
APA
Ficker, E. S., Maranhão, R. C., Chacra, A. P. M., Neves, V. C., Negrão, C. E., Martins, V. C. N., & Vinagre, C. G. C. de M. (2010). Exercise training accelerates the removal from plasma of LDL-like nanoemulsion in moderately hypercholesterolemic subjects. Atherosclerosis, 212( 1), 230-236. doi:10.1016/j.atherosclerosis.2010.04.030
NLM
Ficker ES, Maranhão RC, Chacra APM, Neves VC, Negrão CE, Martins VCN, Vinagre CGC de M. Exercise training accelerates the removal from plasma of LDL-like nanoemulsion in moderately hypercholesterolemic subjects [Internet]. Atherosclerosis. 2010 ; 212( 1): 230-236.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2010.04.030
Vancouver
Ficker ES, Maranhão RC, Chacra APM, Neves VC, Negrão CE, Martins VCN, Vinagre CGC de M. Exercise training accelerates the removal from plasma of LDL-like nanoemulsion in moderately hypercholesterolemic subjects [Internet]. Atherosclerosis. 2010 ; 212( 1): 230-236.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2010.04.030
Artigo de periodico
Paclitaxel associated with cholesterol-rich nanoemulsions promotes atherosclerosis regression in the rabbit (2008)
Maranhão, Raul Cavalcante ; Tavares, Elaine Rufo; Padoveze, Amanda Felippe; Valduga, Claudete Justina; Rodrigues, Debora Garcia; Pereira, Maria das Dores
Source: Atherosclerosis. Unidade: FCF
Subjects: EMULSÕES (FORMAS FARMACÊUTICAS), LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARANHÃO, Raul Cavalcante et al. Paclitaxel associated with cholesterol-rich nanoemulsions promotes atherosclerosis regression in the rabbit. Atherosclerosis, v. 197, n. 2, p. 959-966, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2007.12.051. Acesso em: 07 nov. 2024.
APA
Maranhão, R. C., Tavares, E. R., Padoveze, A. F., Valduga, C. J., Rodrigues, D. G., & Pereira, M. das D. (2008). Paclitaxel associated with cholesterol-rich nanoemulsions promotes atherosclerosis regression in the rabbit. Atherosclerosis, 197( 2), 959-966. doi:10.1016/j.atherosclerosis.2007.12.051
NLM
Maranhão RC, Tavares ER, Padoveze AF, Valduga CJ, Rodrigues DG, Pereira M das D. Paclitaxel associated with cholesterol-rich nanoemulsions promotes atherosclerosis regression in the rabbit [Internet]. Atherosclerosis. 2008 ;197( 2): 959-966.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2007.12.051
Vancouver
Maranhão RC, Tavares ER, Padoveze AF, Valduga CJ, Rodrigues DG, Pereira M das D. Paclitaxel associated with cholesterol-rich nanoemulsions promotes atherosclerosis regression in the rabbit [Internet]. Atherosclerosis. 2008 ;197( 2): 959-966.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2007.12.051
Artigo de periodico
Accumulation of chylomicron remnants and impaired vascular reactivity accur in subjects with isolated low HDL cholesterol: effects of niacin treatment (2006)
Benjó, Alexandre M.; Maranhão, Raul Cavalcante ; Coimbra, Silmara R.; Andrade, Ana C. M.; Favarato, Desiderio; Molina, Marcos S.; Brandizzi, Laura I. V.; Luz, Protásio Lemos da
Source: Atherosclerosis. Unidades: FM, FCF
Subjects: LIPOPROTEÍNAS (METABOLISMO), EMULSÕES GORDUROSAS ENDOVENOSAS (METABOLISMO), CORONARIOPATIA (PATOLOGIA;DIAGNÓSTICO), DOENÇAS VASCULARES (DIAGNÓSTICO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BENJÓ, Alexandre M. et al. Accumulation of chylomicron remnants and impaired vascular reactivity accur in subjects with isolated low HDL cholesterol: effects of niacin treatment. Atherosclerosis, v. 187, n. 1, p. 116-122, 2006Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2005.08.025. Acesso em: 07 nov. 2024.
APA
Benjó, A. M., Maranhão, R. C., Coimbra, S. R., Andrade, A. C. M., Favarato, D., Molina, M. S., et al. (2006). Accumulation of chylomicron remnants and impaired vascular reactivity accur in subjects with isolated low HDL cholesterol: effects of niacin treatment. Atherosclerosis, 187( 1), 116-122. doi:10.1016/j.atherosclerosis.2005.08.025
NLM
Benjó AM, Maranhão RC, Coimbra SR, Andrade ACM, Favarato D, Molina MS, Brandizzi LIV, Luz PL da. Accumulation of chylomicron remnants and impaired vascular reactivity accur in subjects with isolated low HDL cholesterol: effects of niacin treatment [Internet]. Atherosclerosis. 2006 ; 187( 1): 116-122.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2005.08.025
Vancouver
Benjó AM, Maranhão RC, Coimbra SR, Andrade ACM, Favarato D, Molina MS, Brandizzi LIV, Luz PL da. Accumulation of chylomicron remnants and impaired vascular reactivity accur in subjects with isolated low HDL cholesterol: effects of niacin treatment [Internet]. Atherosclerosis. 2006 ; 187( 1): 116-122.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2005.08.025

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Date published

Subjects

Conference titles

Countries/Territories

Indexado em

Non normalized affiliation